A Finished Dosage Form (FDF) refers to the final form of a pharmaceutical product that is ready for administration to a patient without the need for any further modification. This term encompasses a wide variety of drug delivery systems, including tablets, capsules, injections, creams, ointments, and more. The development of FDFs is a critical phase in the pharmaceutical manufacturing process, involving the combination of active pharmaceutical ingredients (APIs) with excipients to create a product that is safe, effective, and convenient for patient use.
TJCY contains other products and information you need, so please check it out.
FDFs are the end-point of pharmaceutical development processes, bringing together science, technology, and regulatory standards to meet the therapeutic needs of patients. By transforming raw chemical compounds into user-friendly forms, FDFs make it possible for patients to accurately dose and safely consume medications. This transformation is essential for the efficacy of the treatment, as it ensures the active ingredient is delivered to the appropriate site of action within the body in the correct dosage and at the right time. Obtaining regulatory approval for an FDF requires several key pieces of information and documentation.
Depending on the region/country where approval is sought, the information & documentation requirements may vary since different regulatory agencies have their own set of guidelines and processes. However, some common data that is required includes:
Product information: details about the FDF like its composition, intended use, dosage strength, dosage form, packaging information & proposed shelf life.
Quality control data: data related to the quality of the product i.e., manufacturing processes, specifications for raw materials & finished products, stability data, analytical methods used for testing, and batch records.
Non-clinical data: pre-clinical studies conducted for assessing safety & efficacy i.e., pharmacology, toxicology, and other relevant studies.
Clinical data: for products intended for human use, clinical data from control trials are required to support the product’s safety and efficacy in humans.
Regulatory documentation: application forms, labelling information, summary of product characteristics (SmPC), and other documents required by regulatory agency.
GMP compliance: evidence of compliance with GMP standards for ensuring quality, safety, and consistency.
In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”
At Sandoo Pharma, we may be very professional in pharmaceutical APIs and intermediates for our clients, but we also want to be understandable to laypeople and the rest of the public. The world of chemicals production can indeed be quite technical and involved, but it means nothing if our work is so opaque as to be confusing.
In that case, we will be using this article to discuss the difference between FDF and API and how these two pieces of the pharmaceutical formulation process are interrelated and what we can do in this field.
WHAT IS AN FDF?
As stated previously, FDF stands for finished dosage form, and it refers to the actual finalized drug product that is meant for consumption. FDFs can take a variety of forms, including solid tablets or capsules, a liquid solution, or another type. FDFs usually contain an API alongside various inactive ingredients.
All drugs are made up of two core components: the API, which is the central ingredient, and the excipient, the substances other than the drug that helps deliver the medication to your system. Excipients are chemically inactive substances, such as lactose or mineral oil in the pill.
Although inactive ingredients play no role in the drug making you feel better, they can have side effects on the body. Read the possible side effects on the next container of prescription medications you get to see how these ingredients might affect you.
Want more information on fdf pharma? Feel free to contact us.
In this case, then, the next time you see “FDF” in reference to pharmaceuticals, you will know the term simply refers to the physical form of the drug that was produced for sale at any pharmacy where customers shop.
WHAT IS AN API?
We just referenced APIs, or active pharmaceutical ingredients, but we can get into some more details here. The Active Pharmaceutical Ingredient (API) is the part of any drug that produces the intended effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways.
Manufacturers use certain standards to determine how strong the API is in each drug. However, the standard can vary widely from one brand to another. Each brand might use different test methods, that can result in different potencies.
In all cases, manufacturers are required by the FDA to prove the potency of their products in real-life patients, as well as in laboratory conditions.
Production of APIs has traditionally been done by the pharmaceutical companies themselves in their home countries. But in recent years many corporations have opted to send manufacturing overseas to cut costs. This has caused significant changes to how these drugs are regulated, with more rigorous guidelines and inspections put into place.
While many pharmaceutical companies are located in the United States and England, most API manufacturers are overseas. The largest are located in Asia, particularly in India and China.
More and more companies are outsourcing to cut costs on expensive equipment, employees, and infrastructure. While this has helped their bottom line, there is continued concern about the quality of these APIs produced overseas.
REGULATIONS
The quality of APIs has a significant effect on the efficacy (producing the result desired) and the safety of medications. Poorly manufactured or compromised APIs have been connected to serious issues, such as illnesses or death.
Even in the case of outsourcing, APIs are subject to stringent regulations and oversight from the country they are shipped to. For example, API manufacturing plants overseas still go through an inspection by the U.S. Food & Drug Administration.
As evidenced by the creation of APIs, the pharmaceutical industry is rapidly changing. Companies no longer handle every step of the drug-making process. One company used to create the API, build the capsule, and package the medicine—but no longer.
In response, governing bodies responsible for patient and public safety have instituted intense screenings to ensure medication quality and prevent defects. Violating any of these established standards can result in fines or very expensive recall for the pharmaceutical companies behind these manufacturers.
WHAT ARE WE DOING?
We Sandoo Pharma, develops many close partner manufacturers, including research and development (R&D) centres and GMP/FDA production facilities. We canoffer API and intermediates along with documents, such as CMC and DMF profiles.
Almost 14 years of experience in supplying pharmaceuticals and chemicals to European, Asian and North of American clients makes Sandoo a reliable partner as it anticipates its customers’ needs. Our company’s main objective is that there is no shortage of raw materials in the r&d and production process of the pharmaceutical company to enable pharmaceutical companies to efficiently and economically develop and produce drugs for the benefit of human society.
If you are looking for more details, kindly visit pharmaceutical formulation intermediates.